Regulation of stem cell fate by FOXO and RNA binding proteins
FOXO 和 RNA 结合蛋白调节干细胞命运
基本信息
- 批准号:10653354
- 负责人:
- 金额:$ 43.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:19pAddressAdoptedAdultBindingCaenorhabditis elegansCell CycleCell Differentiation processCell Fate ControlCell MaintenanceCell ReprogrammingCell divisionCellsChIP-seqCharacteristicsCollagenComplementDataDevelopmentDimensionsDissectionFamilyFoundationsGene ExpressionGenesGeneticGenetic TranscriptionGoalsHealthHumanKnowledgeLarvaLinkLobular NeoplasiaMaintenanceMammalsMessenger RNAMicroRNAsMissionMonitorNational Institute of General Medical SciencesOrganOrthologous GeneOutcomePathway interactionsPatternPhenotypeProliferatingProteinsRNA InterferenceRNA-Binding ProteinsRegulationReporterResearchResolutionRoleSystemTestingTissuesTranscriptional RegulationTransgenesTranslational RepressionUnited States National Institutes of HealthWorkcell injurycell typeclinical applicationexperimental studyflygain of functionin vivoinnovationloss of functionmRNA sequencingmultipotent cellmutantnovelpreservationpromoterresponseself renewing cellstemstem cell biologystem cell fatestem cell modelstem cellstranscription factorundergraduate student
项目摘要
A fundamental gap exists in the understanding of how developmental pathways are regulated to maintain
stem cell multipotency during extended periods of quiescence, or non-division. The FOXO family of
transcription factors are key regulators of stem cell maintenance and quiescence. However, the
mechanisms by which FOXO proteins impact developmental pathways to control cell fate are poorly
understood. This application capitalizes on the power of the C. elegans system to address the
mechanisms by which the single FOXO ortholog, daf-16, regulates conserved developmental pathways to
preserve stem cell multipotency during quiescence. To model stem cell quiescence, we will use the
quiescent dauer larva stage, adopted midway through development in response to adverse environmental
conditions. This approach is innovative because the C. elegans system allows us to study quiescent,
multipotent cells in vivo at single cell resolution, complementing mammalian studies. The long-term goal of
this lab is to decipher the mechanisms that promote multipotency during dauer. Epidermal seam cells, the
stem cell model, are multipotent and undergo a characteristic pattern of self-renewing cell divisions at
each larval stage until differentiating at adulthood. During dauer, seam cells are quiescent and active
mechanisms maintain multipotency. Preliminary data establish that during dauer, FOXO/daf-16 blocks
adult cell fate by positively regulating the expression of three genes that encode RNA-binding proteins
(RBPs). The orthologs of these RBPs regulate the proliferation and function of stem and progenitor cells in
flies and mammals. The objective of this application is to unravel the mechanisms by which FOXO/daf-16
acts via RBPs to regulate adult cell fate during the quiescent dauer stage. Three specific aims are
proposed to meet this objective. 1) Determine the genetic relationship between FOXO/daf-16 and RBPs.
Loss-of-function and gain-of-function experiments will establish the regulation of RBPs by FOXO/daf-16, a
novel mechanism to control cell fate. 2) Identify direct RBP targets that block adult cell fate during
quiescence. Direct mRNA targets of RBPs will be identified by iCLIP. Functional testing will determine
which targets are involved in the regulation of seam cell fate. Together these experiments will elucidate
the connection between FOXO/daf-16-regulated RBPs and adult cell fate. 3) Dissect the transcriptional
regulation of an adult cell fate marker during quiescence. Preliminary data establish that during dauer,
FOXO/daf-16 and the three RBPs block expression of a transcriptional reporter of an adult-specific gene,
widely used to mark adult cell fate. Promoter dissection and functional testing of candidate transcription
factors will decipher the quiescence-specific regulation of a key adult cell fate marker. The proposed work
is significant because it will illuminate how the regulation of developmental pathways is coordinated with
the regulation of quiescence in multipotent cells.
在理解如何调节发育途径以维持
干细胞在长时间的静止期或非分裂期具有多能性。FOXO系列的
转录因子是干细胞维持和静止的关键调节因子。然而,
FOXO蛋白影响发育途径以控制细胞命运的机制很差
明白了。此应用程序利用线虫系统的强大功能来解决
单一FOXO同源基因daf-16调节保守的发育途径的机制
在静止状态下保持干细胞的多能性。为了模拟干细胞静止,我们将使用
静止的达尔幼虫阶段,在发育中期被采用,以应对不利的环境
条件。这种方法是创新的,因为线虫系统允许我们研究静止的,
体内单细胞分辨率的多潜能细胞,补充哺乳动物的研究。的长期目标是
这个实验室是为了破译在Dauer过程中促进多能性的机制。表皮缝隙细胞,
干细胞模型是多能的,并经历一种特有的自我更新的细胞分裂模式
每个幼虫阶段,直到成虫分化。在Dauer过程中,Seam细胞处于静止和活跃状态
这些机制保持了多功能性。初步数据证实,在DAUER期间,FOXO/DAF-16块
正向调节编码RNA结合蛋白的三个基因表达的成体细胞命运
(限制性商业惯例)。这些限制性商业惯例的直系物调节干细胞和祖细胞的增殖和功能。
苍蝇和哺乳动物。本申请的目的是解开FOXO/DAF-16
通过限制性商业惯例在静止的达尔阶段调节成体细胞的命运。三个具体目标是
建议实现这一目标。1)确定FOXO/DAF-16与限制性商业惯例的遗传关系。
功能丧失和功能获得实验将建立FOXO/daf-16对限制性商业惯例的调节,a
控制细胞命运的新机制。2)识别直接阻止成体细胞命运的RBP靶点
宁静。限制性商业惯例的直接信使核糖核酸靶点将通过iCLIP确定。功能测试将确定
哪些靶点参与调节Seam细胞的命运。这些实验将共同阐明
FOXO/DAF-16调控的限制性商业惯例与成体细胞命运的关系。3)剖析转录
成体细胞命运标记在静止期的调节。初步数据表明,在达乌尔期间,
FOXO/DAF-16和三个限制性商业惯例阻断成体特异基因转录报告的表达,
广泛用于标记成年细胞的命运。候选转录的启动子解剖和功能测试
这些因素将破译一个关键的成年细胞命运标记的静止期特异性调节。拟议中的工作
具有重要意义,因为它将阐明发育途径的调节是如何与
多能细胞中静止状态的调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XANTHA KARP其他文献
XANTHA KARP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XANTHA KARP', 18)}}的其他基金
Genetics of postdauer developmental timing in C elegans
线虫后发育时间的遗传学
- 批准号:
6883770 - 财政年份:2005
- 资助金额:
$ 43.45万 - 项目类别:
Genetics of postdauer developmental timing in C elegans
线虫后发育时间的遗传学
- 批准号:
7227467 - 财政年份:2005
- 资助金额:
$ 43.45万 - 项目类别:
Genetics of postdauer developmental timing in C elegans
线虫后发育时间的遗传学
- 批准号:
7547527 - 财政年份:2005
- 资助金额:
$ 43.45万 - 项目类别:
Genetics of postdauer developmental timing in C elegans
线虫后发育时间的遗传学
- 批准号:
7067125 - 财政年份:2005
- 资助金额:
$ 43.45万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 43.45万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 43.45万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 43.45万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 43.45万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 43.45万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 43.45万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 43.45万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 43.45万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 43.45万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 43.45万 - 项目类别:
Research Grant














{{item.name}}会员




